Browsing by Subject "Liver Fibrosis"
Now showing items 1-5 of 5
-
Aspectos evolutivos de pacientes hemofílicos infectados pelo vírus da hepatite C
(Universidade Federal de São Paulo (UNIFESP), 2020-12-10)Introduction: The improvement in the treatment of hemophilia from the 90's, as well as the advent of interferon-free therapy against the hepatitis C virus (HCV) for infected patients, enabled a better evolution of these ...
-
Avaliação da evolução da Fibrose Hepática em pacientes cirróticos com resposta virológica sustentada após tratamento de Hepatite C crônica
(Universidade Federal de São Paulo (UNIFESP), 2019-09-11)Background The advent of chronic hepatitis C therapy with direct acting antiviral agents (DAAs) without interferon made possible a cure rate in more than 90% of the infected patients and allowed the evaluation, through ...
-
Avaliação da Fibrose Hepática por Elastografia nos pacientes portadores de Esquistossomose Mansônica
(Universidade Federal de São Paulo (UNIFESP), 2019-06-11)Introduction: Schistosomiasis persists as an important public health problem. Its main pathogenic event is hepatic fibrosis, associated with disease progression and its prognosis. The applicability of hepatic elastography ...
-
Transient elastography and apri score: looking at false positives and false negatives. Diagnostic performance and association to fibrosis staging in chronic hepatitis c
(Hindawi Ltd, 2016)Although long regarded as the gold standard for liver fibrosis staging in chronic hepatitis C (CHC), liver biopsy (LB) implies both the risk of an invasive procedure and significant variability. The aim of this study was ...
-
Valor da elastografia hepática transitória isoladamente ou em associação a biomarcadores no estadiamento da doença hepática gordurosa não alcoólica
(Universidade Federal de São Paulo (UNIFESP), 2019-09-26)Introduction: The prevalence of non-alcoholic fatty liver disease (NAFLD) has significantly increased in the world, affecting up to 30% of the Western population. It is associated with hepatic and systemic complications, ...
